echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Neurology: Comparison of efficacy of Ubroxide for mild pain and moderate or severe pain migraine

    Neurology: Comparison of efficacy of Ubroxide for mild pain and moderate or severe pain migraine

    • Last Update: 2022-10-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    During a migraine attack, the initial mild pain usually escalates to moderate or severe pain


    Recently, a research article was published in Neurology, an authoritative journal in the field of neurology.


    In this phase 3, open-label, dose-blind, 52-week trial, adults with migraine were randomized 1:1 (usually, ubbrosu-50 mg, or ublosu-100 mg)


    The study included data on 19,291 migraine attacks from 808 participants


    CONCLUSIONS: Compared with moderate or severe pain episodes, patients with mild pain had significantly higher rates of pain relief, associated symptoms, and return to normal function within 2 hours of treatment with Ubroxide


    Original source:

    Richard B.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.